antengene website screenshot

antengene

Antengene Corporation is a commercial-stage, R&D-driven global biopharmaceutical company focused on discovering, developing, and commercializing first-in-class and best-in-class therapies for the treatment of hematologic malignancies and solid tumors. Headquartered in Shanghai with a global footprint across the Asia Pacific region and beyond, Antengene's marketed product XPOVIO (selinexor) and a pipeline of oncology assets such as the Claudin 18.2 antibody-drug conjugate ATG-022 and the CD73 inhibitor ATG-037 target unmet needs in cancer care. Antengene operates in the life sciences sector and does not currently publish a public developer API, SDK, or developer portal; this profile was surfaced as a portfolio company of Qiming Venture Partners and captured in the API Evangelist network for company intelligence and enrichment.

antengene is profiled on the APIs.io network. Tagged areas include Company, Biopharmaceutical, Oncology, Pharmaceuticals, and Healthcare.

antengene’s developer surface includes engineering blog and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub
14.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiopharmaceuticalOncologyPharmaceuticalsHealthcareLife SciencesDrug Development

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 14.3/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.4 / 20
Commercial Clarity 4.2 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/antengene: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Antengene Domain Security

TLSv1.3 · HSTS

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy
 TermsOfService
TermsOfService

Company 2

The organization behind the API

Website
Website
 Blog
Blog

Source (apis.yml)

apis.yml Raw ↑ 
aid: antengene
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/antengene.png
name: antengene
description: Antengene Corporation is a commercial-stage, R&D-driven global biopharmaceutical company focused on discovering,
  developing, and commercializing first-in-class and best-in-class therapies for the treatment of hematologic malignancies
  and solid tumors. Headquartered in Shanghai with a global footprint across the Asia Pacific region and beyond, Antengene's
  marketed product XPOVIO (selinexor) and a pipeline of oncology assets such as the Claudin 18.2 antibody-drug conjugate ATG-022
  and the CD73 inhibitor ATG-037 target unmet needs in cancer care. Antengene operates in the life sciences sector and does
  not currently publish a public developer API, SDK, or developer portal; this profile was surfaced as a portfolio company
  of Qiming Venture Partners and captured in the API Evangelist network for company intelligence and enrichment.
url: https://raw.githubusercontent.com/api-evangelist/antengene/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- qiming
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-17'
humanURL: https://antengene.com
tags:
- Company
- Biopharmaceutical
- Oncology
- Pharmaceuticals
- Healthcare
- Life Sciences
- Drug Development
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/antengene-domain-security.yml
- type: Website
  url: https://antengene.com
- type: PrivacyPolicy
  url: https://antengene.com/about.html
- type: TermsOfService
  url: https://antengene.com/about.html
- type: Blog
  name: Newsroom
  url: https://antengene.com/news.html
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence